MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY AND STOCK-BASED COMPENSATION - Narrative (Details)

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended					9 Months Ended		12 Months Ended
	Jun. 08, 2023	Feb. 21, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jan. 24, 2023	Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Award vesting period	1 year
Warrants to purchase common stock (in shares)			42,199,476					42,199,476
Exercise price of warrants (in dollars per share)			$ 0.68					$ 0.68				$ 1.087
Issuance of subscribed shares (in shares)							2,717	5,025
Number of shares converted to common stock (in shares)			25,304,710					25,304,710
Stock based compensation			$ 300			$ 1,400		$ 800	$ 6,400
Issuance of subscribed shares				$ 0	$ 0		$ 0
Amended and Restated 2018 Stock Award and Incentive Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expiration term								5 years
Weighted average remaining life								3 years
Mari Holdings MD LLC
Accumulated Other Comprehensive Income (Loss) [Line Items]
Ownership interest acquired			0.33%					0.33%
Ermont Acquisition
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued as consideration transferred (in shares)		6,580,390
Share-Based Payment Arrangement, Employee \| Common stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for payment of royalties (in shares)								8,613
Value of shares issued for payment of royalties								$ 3
Minority Interest Holder
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price of warrants (in dollars per share)			$ 0.40					$ 0.40
Restricted Stock Units (RSUs) \| Minority Interest Holder
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued to purchase property and equipment (in shares)								450,000
Warrant \| Minority Interest Holder
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock (in shares)			400,000					400,000
Restricted Stock \| Ermont Acquisition
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued as consideration transferred (in shares)								6,580,390
Value of stock issued for consideration			$ 3,000					$ 3,000
Restricted Stock \| Share Based Payment Arrangement, Two Employees
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of subscribed shares (in shares)								70,000		70,000
Issuance of subscribed shares										$ 39
Restricted Stock \| Share Based Payment Arrangement, Two Nonemployee Service Providers \| Common stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued as payment of fees (in shares)								1,140,741
Stock issued for services								$ 460
Series C Preferred Stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares converted (in shares)								5,060,942
Loan and Security Agreement \| Secured Debt
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock (in shares)											19,148,936
Exercise price of warrants (in dollars per share)											$ 0.47
Term of warrants (in years)											5 years